The third time is a charm for New Jersey’s Johnson & Johnson, as the pharmaceutical and biotech giant attempts to get a court-issued seal of approval on its long-awaited settlement offer and subsidiary bankruptcy plan, which is sitting before a Houston federal courtroom this week. Red River Talc LLC, the subsidiary tasked with handling the thousands of…